FREE SHIPPING ON ORDERS OVER $150

foxo4-dri senolytic peptide human trials The disordered p53 transactivation domain is the target of FOXO4 and the compound The disordered p53 transactivation domain

$24.26

Quantity
- +
Description

Supplied as a stable lyophilised solid for controlled handling

foxo4-dri senolytic peptide human trials The disordered p53 transactivation domain is the target of FOXO4 and the compound The disordered p53 transactivation domain

Manufactured By: Schazoo Pharmaceuticals

foxo4-dri senolytic peptide human trials The disordered p53 transactivation domain is the target of FOXO4 and the compound The disordered p53 transactivation domain

This cell-permeable peptide antagonist blocks the interaction of FOXO4 and p53.

foxo4-dri senolytic peptide human trials The disordered p53 transactivation domain is the target of FOXO4 and the compound The disordered p53 transactivation domain

Sold by the vial 2ml

foxo4-dri senolytic peptide human trials The disordered p53 transactivation domain is the target of FOXO4 and the compound The disordered p53 transactivation domain

You may also like

BPC-157 5mg

US$ 28.54

5.0 (9 reviews)

recommand products